Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Specific brain sites for the opiate abstinence syndrome syndrome have been elusive to delineate, and the classic overt signs of withdrawal such as wet dog shakes, ptosis and teeth chattering appear to be widely represented in the brain. Using a more general motivational test involving a disruption of operant behavior in dependent rats, the brain site most sensitive to the response disruptive effects of intracerebral administration of the opiate antagonist, methylnaloxonium, was the region of the nucleus accumbens, a site also implicated in the acute reinforcing properties of opiates. This disruption of operant responding was hypothesized to reflect the aversive properties of opiate withdrawal. The present study directly tested that hypothesis by exploring whether intercerebral administration of methylnaloxonium produced aversive stimulus effects as measured by the formation of place aversions. Rats implanted intracerebroventricularly or with bilateral cannulae aimed at the medial dorsal thalamus, periaqueductal gray, ventral tegmental area, amygdala or nucleus accumbens were made dependent on morphine by subcutaneous implantation of two 75-mg morphine pellets. The animals were then subjected to place aversion training by pairing of a distinct environment (one of three arms of a three-armed box with distinct texture, markings and smell) with a single injection of methylnaloxonium intracerebroventricularly or intracerebrally. Results showed that at high doses of methylnaloxonium (1000-2000 ng) all sites produced a place aversion. However, lower doses (250-500 ng) produced a significant brain site selectivity with the region of the nucleus accumbens the most sensitive. Observational measurements taken during the postinjection period with the high dose of methylnaloxonium showed that agitation was particularly observed following methylnaloxonium administration into the nucleus accumbens and periaqueductal gray.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other observed changes include increases in μ opioid receptor responsivity during opioid withdrawal,71,72 and decreases in GABAergic and increases in NMDA glutamatergic transmission in the nucleus accumbens.”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [71]
Citations
Cites
Nonparametric Statistics for the Behavioral Sciences
Guitton, H., & Siegel, S. (1958) · Revue économique · doi:10.2307/3498751 · Cited by 35,245
Nonparametric Statistics for the Behavioral Sciences.
Whitfield, J. W., & Siegel, S. (1957) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2342828 · Cited by 7,947
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
A stereotaxic atlas of the rat brain
Pellegrino, L. J., & Cushman, A. J. (1967) · Plenum Press eBooks · Cited by 4,688
A stereotaxic atlas of the rat brain
Brodal, P. (1980) · Neuroscience · doi:10.1016/0306-4522(80)90013-5 · Cited by 2,782
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Self-citation[Drug addiction and drug abuse].
Feuerlein, W. (1969) · PubMed · Cited by 1,415
Goodman and Gilman's The Pharmacological Basis of Therapeutics
Fraunfelder, F. T. (1981) · American Journal of Ophthalmology · doi:10.1016/0002-9394(81)90318-4 · Cited by 1,331
Mucha, R. F., & Herz, A. (1985) · Psychopharmacology · doi:10.1007/bf00432213 · Cited by 510
Drug dependence: its significance and characteristics.
Eddy, N. O., Halbach, H., Isbell, H., & Seevers, M. H. (1965) · Europe PMC (PubMed Central) · Cited by 297
Research works printed but not linked: 1
- Adler, 1978, Inability of acute or chronic thalamic, limbic, or cortical lesions to alter narcotic dependence and abstinence in rats, Devl Neurosci., 4, 51
Cited by
Items 201–300 of 316
Ethological analysis of morphine withdrawal with different dependence programs in male mice
Broseta, I., Rodríguez‐Arias, M., Stinus, L., & Miñarro, J. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00277-9 · Cited by 26
Self-citationRossbach, U. L., Nilsson, A., Fälth, M., Kultima, K., Zhou, Q., Hallberg, M., Gordh, T., Andrén, P. E., & Nyberg, F. (2009) · Journal of Proteome Research · doi:10.1021/pr800669g · Cited by 25
Peripheral withdrawal recruits distinct central nuclei in morphine-dependent rats
Hamlin, A. S., Buller, K. M., Day, T. A., & Osborne, P. B. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00101-0 · Cited by 25
Gómez-Milanés, I., Almela, P., García-Carmona, J. A., García‐Gutiérrez, M. S., Aracil-Fernández, A., Manzanares, J., Milanés, M. V., & Laorden, M. L. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.06.011 · Cited by 28
Sticht, M. A., Mitsubata, J., Tucci, M. C., & Leri, F. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.10.005 · Cited by 28
Chartoff, E. H., Barhight, M. F., Mague, S. D., Sawyer, A. M., & Carlezon, W. A. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1454-7 · Cited by 28
Maldonado, C., Rodríguez‐Arias, M., Aguilar, M. A., & arro, J. M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1927-2 · Cited by 23
Is dopamine important in nicotine dependence?
Shoaib, M. C. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80024-7 · Cited by 26
Rock, E. M., Ayoub, S. M., Limebeer, C. L., Gene, A., Wills, K. L., DeVuono, M. V., Smoum, R., Marzo, V. D., Lichtman, A. H., Mechoulam, R., et al. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05373-2 · Cited by 25
Glass, M. J. (2010) · Vitamins and hormones · doi:10.1016/s0083-6729(10)82008-4 · Cited by 24
Jin, C., Araki, H., Nagata, M., Shimosaka, R., Shibata, K., Suemaru, K., Kawasaki, H., & Gomita, Y. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.01.012 · Cited by 24
Opiate withdrawal in the infant
Barr, G. A., & Jones, K. L. (1994) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(94)90121-x · Cited by 23
Davis, M., & Lang, P. J. (2003) · Wiley eBooks · doi:10.1002/0471264385.wei0315 · Cited by 37
Criner, S. H., Liu, J., & Schulteis, G. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.002 · Cited by 22
Suzuki, T., Tsuji, M., Mori, T., Misawa, M., & Nagase, H. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02139-a · Cited by 21
Déjean, C., Sitko, M., Girardeau, P., Bennabi, A., Caillé, S., Cador, M., Boraud, T., & Moine, C. L. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.272 · Cited by 25
Opioid withdrawal and memory consolidation
Baidoo, N., Wolter, M., & Leri, F. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.03.029 · Cited by 22
Becker, C., Pohl, M., Thiébot, M.-H., Collin, E., Hamon, M., Cesselin, F., & Benoliel, J. J. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00161-6 · Cited by 19
Low expression of D2R and Wntless correlates with high motivation for heroin.
Tacelosky, D. M., Alexander, D. N., Morse, M., Hajnal, A. S., Berg, A. S., Levenson, R. G., & Grigson, P. S. (2015) · Behavioral Neuroscience · doi:10.1037/bne0000104 · Cited by 21
Neurobiology of aversive states
Umberg, E. N., & Pothos, E. N. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.04.045 · Cited by 24
NMDA Receptor in Nucleus Accumbens is Implicated in Morphine Withdrawal in Rats
Dong, J., Sui, Z., Ma, Y., Luo, F., Cui, C., & Han, J. (2004) · Neurochemical Research · doi:10.1007/s11064-004-6884-y · Cited by 19
Felip, C. M., Rodríguez‐Arias, M., Fernández‐Espejo, E., Miñarro, J., & Stinus, L. (2000) · Behavioral Neuroscience · doi:10.1037//0735-7044.114.2.424 · Cited by 19
Self-citationInvolvement of mesolimbic κ-opioid systems in the discriminative stimulus effects of morphine
Spanagel, R., & Shoaib, M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90524-x · Cited by 22
Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome
Caillé, S., Fernández‐Espejo, E., Koob, G. F., & Stinus, L. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00810-9 · Cited by 18
Self-citationOpioid Dependence and NMDA Receptors
Glass, M. J. (2011) · ILAR Journal · doi:10.1093/ilar.52.3.342 · Cited by 21
Narp regulates long-term aversive effects of morphine withdrawal.
Reti, I. M., Crombag, H. S., Takamiya, K., Sutton, J. M., Guo, N., Dinenna, M. L., Huganir, R. L., Holland, P. C., & Baraban, J. M. (2008) · Behavioral Neuroscience · doi:10.1037/a0012514 · Cited by 20
Upadhyay, J., Verrico, C. D., Cay, M., Kodele, S., Yammine, L., Koob, G. F., & Schreiber, R. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00008-0 · Cited by 20
Self-citationKozela, E., Wróbel, M., Kos, T., Wójcikowski, J., Daniel, W. A., Wozniak, K. M., Slusher, B. S., & Popik, P. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0182-5 · Cited by 17
BRAIN FUNCTIONS AND PSYCHIATRIC DISORDERS
Othmer, E., Othmer, J. P., & Othmer, S. C. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70022-8 · Cited by 18
Conditioned taste aversion from neostigmine or methyl-naloxonium in the nucleus accumbens
Taylor, K. M., Mark, G. P., & Hoebel, B. G. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.04.050 · Cited by 18
Baidoo, N., Wolter, M., Holahan, M. R., Epp, T., Winters, B. D., & Leri, F. (2020) · Addiction Biology · doi:10.1111/adb.12909 · Cited by 19
Omoigui, S., Hashmat, F., & Bernardo, Z. (2011) · The Open Pain Journal · doi:10.2174/1876386301104010001 · Cited by 16
Hooshmandi, M., Hosseinmardi, N., Janahmadi, M., Khakpai, F., Rohampour, K., & Doostmohammadi, J. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.06.001 · Cited by 16
Caillé, S., Rodríguez‐Arias, M., Miñarro, J., Fernández‐Espejo, E., Cador, M., & Stinus, L. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.5.995 · Cited by 18
Self-citationPuig, S., Shelton, M. A., Barko, K., Seney, M. L., & Logan, R. W. (2022) · Genes Brain & Behavior · doi:10.1111/gbb.12829 · Cited by 14
Preferences for Tastes Paired With a Nicotine Antagonist in Rats Chronically Treated With Nicotine
Mucha, R. F. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00173-6 · Cited by 16
Involvement of the midbrain tectum in the unconditioned fear promoted by morphine withdrawal
Ávila, M. A. V., Ruggiero, R. N., Cabral, A., Brandão, M. L., Nobre, M. J., & Castilho, V. M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.030 · Cited by 15
Caillé, S., Stinus, L., Fernández‐Espejo, E., Deurwaerdère, P. D., Spampinato, U., & Koob, G. F. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300033 · Cited by 18
Self-citationAhmadi‐Soleimani, S. M., Mohammadi-Mahdiabadi-Hasani, M.-H., Raoufy, M. R., Azizi, H., Nasehi, M., & Zarrindast, M. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.09.016 · Cited by 17
Li, Y., Liu, X., Chen, H., Deng, H., Xiang, X., Chen, H., & Hao, W. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00059.x · Cited by 15
Kraus, M. A., Piper, J. M., & Kornetsky, C. H. (1996) · Brain Research · doi:10.1016/0006-8993(96)00263-6 · Cited by 15
Pedrón, V. T., Varani, A. P., & Balerio, G. N. (2016) · Synapse · doi:10.1002/syn.21886 · Cited by 16
Shippenberg, T. S., Funada, M., & Schütz, C. G. (2000) · Psychopharmacology · doi:10.1007/s002130000475 · Cited by 14
The Role of Epigenetics in Addiction: Clinical Overview and Recent Updates
Beayno, A., Hayek, S. E., Noufi, P. E., Tarabay, Y., & Shamseddeen, W. A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9554-7_35 · Cited by 13
Zhou, Q., Kindlundh, A. M. S., Hallberg, M., & Nyberg, F. (2004) · Peptides · doi:10.1016/j.peptides.2004.07.011 · Cited by 13
Bockstaele, E. J. V., Rudoy, C., Mannelli, P., Oropeza, V. C., & Qian, Y. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20738 · Cited by 18
Nakagawa, T., Minami, M., Katsumata, S., Ienaga, Y., & Satoh, M. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb17223.x · Cited by 13
Further studies of the role of opioid receptors in the nigra in the morphine withdrawal syndrome
Baumeister, A., Richard, A. L., Richmond-Landeche, L., Hurry, M. J., & Waguespack, A. M. (1992) · Neuropharmacology · doi:10.1016/0028-3908(92)90119-a · Cited by 13
Anderson, E. M., Neubert, J. K., & Caudle, R. M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.07.037 · Cited by 12
Learning and Memory in Addiction
Carmack, S. A., Koob, G. F., & Anagnostaras, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.21101-2 · Cited by 17
Self-citationJones, K. L., & Barr, G. A. (2000) · Synapse · doi:10.1002/1098-2396(200102)39:2<139::aid-syn5>3.0.co;2-# · Cited by 13
Opioid Withdrawal Abruptly Disrupts Amygdala Circuit Function by Reducing Peptide Actions
Gregoriou, G. C., Patel, S., Pyne, S., Winters, B. L., & Bagley, E. E. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1317-22.2022 · Cited by 11
Li, Y., Li, G.-Y., Li, L., WANG, C.-H., Li, Z.-X., ZHANG, J.-L., Zhang, J., & Li, W. (2007) · International Journal of Neuroscience · doi:10.1080/00207450600936619 · Cited by 13
Azar, M. R., Ahmed, S. H., Lintz, R., Gutierrez, T., Stinus, L., & Koob, G. F. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2003.12.008 · Cited by 11
Self-citationRegional Fos expression induced by morphine withdrawal in the 7‐day‐old rat
McPhie-Lalmansingh, A. A., & Barr, G. A. (2009) · Developmental Psychobiology · doi:10.1002/dev.20392 · Cited by 11
Ishida, S., Shimosaka, R., Kawasaki, Y., Jin, C., Kitamura, Y., Araki, H., Sendo, T., & Gomita, Y. (2008) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.128.395 · Cited by 13
Yi, H., Iida, T., Liu, S., Ikegami, D., Liu, Q., Iida, A., Lubarsky, D. A., & Hao, S. (2017) · Gene Therapy · doi:10.1038/gt.2017.11 · Cited by 10
Animal Models of Drug Dependence: Motivational Perspective
Koob, G. F. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_15 · Cited by 10
Self-citationEffect of nimodipine on morphine-related withdrawal syndrome in rat model: An observational study
Barik, M., Mishra, P., & Ray, S. (2017) · Journal of Pediatric Neurosciences · doi:10.4103/1817-1745.205652 · Cited by 10
Brent, P. J., & Chahl, L. A. (1991) · Neurochemical Research · doi:10.1007/bf00974870 · Cited by 10
Ross, J. D., Ávila, M. A. V., Ruggiero, R. N., Nobre, M. J., Brandão, M. L., & Castilho, V. M. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.05.033 · Cited by 10
Sato, M., Wada, K., & Funada, M. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.06.033 · Cited by 9
Chester, J. A., & Coon, L. E. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.02.001 · Cited by 10
Katsumata, S., Minami, M., Nakagawa, T., & Satoh, M. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00112-x · Cited by 8
Noda, Y., Mamiya, T., & NABESHIMA, T. (2001) · Folia Pharmacologica Japonica · doi:10.1254/fpj.117.21 · Cited by 8
Kosten, T. A., & Bombace, J. C. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00180-4 · Cited by 8
Kimes, A. S., Maldonado, R. J., Ambrosio, E., Koob, G. F., & London, E. D. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00813-0 · Cited by 8
Self-citationWilson, M. A., & McDonald, A. J. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-815134-1.00008-8 · Cited by 9
Extended amygdala, conditioned withdrawal and memory consolidation
Baidoo, N., & Leri, F. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110435 · Cited by 8
Mediating the Effects of Drug Abuse: The Role of Narp in Synaptic Plasticity
Reti, I. M., Blouin, A. M., Worley, P. F., Holland, P. C., Johnson, A. W., & Baraban, J. M. (2011) · ILAR Journal · doi:10.1093/ilar.52.3.321 · Cited by 8
Koob, G. F., & Moal, M. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012419239-3/50041-2 · Cited by 8
Self-citationSheveleva, M. V., Lebedev, A. A., Roik, R. O., & Shabanov, P. D. (2013) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf1133-19 · Cited by 5
ZHANG, J.-J., LIU, X.-D., & Yu, L. (2016) · Physiological Research · doi:10.33549/physiolres.933027 · Cited by 6
García‐Pérez, D., & Milanés, M. V. (2019) · Addiction Biology · doi:10.1111/adb.12728 · Cited by 6
Sensitization to morphine withdrawal in guinea-pigs
Mizutani, A., Arvidsson, J., & Chahl, L. A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.12.043 · Cited by 6
Complementary Therapies for the Body, Mind and Soul
Saad, M. (2015) · InTech eBooks · doi:10.5772/59418 · Cited by 5
Acupuncture on the Stress‐Related Drug Relapse to Seeking
Roh, H. S., Park, B. R., Jang, E. Y., Kim, J. S., & Gwak, Y. S. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/5367864 · Cited by 7
Yi, H., Gu, J., Hamilton, P. J., Liu, S., Zhu, S., Ikegami, D., Hayashi, K., Kashiwagi, Y., Iida, T., Liu, Q., et al. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1934-24.2025 · Cited by 5
Neural mechanisms underlying morphine withdrawal in addicted patients: a review
Babhadi‐Ashar, N., Vaseghi, G., Rafieian‐Kopaei, M., Andalib, S., Eshraghi, A., & Masoudian, N. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.17463/rcm.2015.03.010 · Cited by 5
Guo, L., Yu, C. F., Ling, Q., Fu, Y., Wang, Y., & Liu, J. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112008 · Cited by 5
Common Substrates of Dysphoria in Stimulant Drug Abuse and Primary Depression: Therapeutic Targets
Baicy, K., Bearden, C. E., Monterosso, J. R., Brody, A. L., Isaacson, A. J., & London, E. D. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(04)65005-7 · Cited by 4
Westbrook, R. F., Harris, J. A., Good, A. J., & Paxinos, G. (1992) · The Quarterly Journal of Experimental Psychology Section B · doi:10.1080/14640749208401012 · Cited by 4
5-HT2A receptor inverse agonist attenuates morphine withdrawal syndrome and its aversiveness in rats
Tsai, P.-H., Morales, E. R., Reed, Y. Y., Qamar, H., Jones, E. F., Saji, G., Ward, C. P., Burstein, E. S., Moreno, G. L., & Malin, D. H. (2025) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000832 · Cited by 3
Sánchez, M., & Miquel (2003) · Repositori digital de la UPF (Universitat Pompeu Fabra) · Cited by 3
Neuropsychopharmacology of Opiate Dependence
Maldonado, R. J., Stinus, L., & Koob, G. F. (1996) · Neuroscience intelligence unit · doi:10.1007/978-3-662-22218-8_5 · Cited by 3
Self-citationNegative Reinforcement Mechanisms in Addiction
George, O. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812202-0.00012-9 · Cited by 2
Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-816988-9.00001-1 · Cited by 2
Self-citationAnimal Models of Opiate Dependence
Maldonado, R. J., Stinus, L., & Koob, G. F. (1996) · Neuroscience intelligence unit · doi:10.1007/978-3-662-22218-8_2 · Cited by 2
Self-citationRole of Acupuncture in the Treatment of Drug Addiction
Xiang, A., Zhang, B., & Liu, S. (2015) · InTech eBooks · doi:10.5772/60655 · Cited by 3
Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816863-9.00002-9 · Cited by 2
Self-citationRasmussen, K. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-306-4_22 · Cited by 6
Ziółkowska, B., Gieryk, A., & Przewłocki, R. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00769-8 · Cited by 2
Neuronal Mediation of Addictive Behavior
Koob, G. F. (1998) · CRC Press eBooks · doi:10.1201/9781420048247.ch22 · Cited by 1
Self-citationOpiate withdrawal-like behavior induced by naloxone following exposure to a contextual fear stimulus
Abrahamsen, G. C., Caldarone, B. J., Stock, H. S., Mongeluzi, D. L., & Rosellini, R. A. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00071-2 · Cited by 1
Neuronal Mediation of Addictive Behavior
Koob, G. F. (2019) · CRC Press eBooks · doi:10.1201/9780429114373-23 · Cited by 1
Self-citationLocal control of dopamine release in nucleus accumbens gates opioid withdrawal aversionPreprint
Pomrenze, M. B., Tucciarone, J., Touponse, G. C., Denomme, N., Phan, B. N., Laurent, R. S., Soares, J. A. G., Pinto, D. F. C., Guo, M. Y., Baek, J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.25.727738 · Cited by 2
Study of the interaction between 3,4 methylenedioximethamphetamine and the endocannabinoid system
Touriño, C. (2009) · Repositori digital de la UPF (Universitat Pompeu Fabra)
Behavioral and neurobiological consequences of intermittent exposure to addictive drugs.
Rothwell, P. E. (2010) · University of Minnesota Digital Conservancy (University of Minnesota)
Orexin Neural Activity Associated with Morphine Spontaneous Withdrawal-Induced Anxiety in Rats
Ly, R. (2011) · Digital Commons @ Connecticut College (Connecticut College)
Radke, A. K. (2011) · University of Minnesota Digital Conservancy (University of Minnesota)
Metadata
- Authors
- Stinus, L., Le Moal, M., & Koob, G. F.
- Affiliations
- Inserm (FR)
- Scripps Research Institute (US)
- Corresponding author
- Koob, G.F.
- ORCID
- Koob, G.F.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 1990-01
- Volume
- 37
- Issue
- 3
- Pages
- 767-773
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2043787639
- Cited by
- 317
- References
- 23
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 5 · 2022: 1 · 2021: 4 · 2020: 6 · 2019: 7 · 2018: 7 · 2017: 8 · 2016: 5 · 2015: 5 · 2014: 6 · 2013: 5 · 2012: 6
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (NIDA04043, R01DA004043)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- opioid withdrawal, nucleus accumbens, amygdala, place aversion, morphine dependence, periaqueductal gray, mediodorsal thalamus, ventral tegmental area, intracerebral administration, agitation
- MeSH terms
- Quaternary Ammonium Compounds, Amygdala, Animals, Conditioning, Operant, Injections, Intraventricular, Male, Morphine Dependence, Naloxone, Nucleus Accumbens, Rats, Inbred Strains, Substance Withdrawal Syndrome, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.